RESMED INC — Director's Dealing 2018

Nov 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-09

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-09	ResMed Common Stock	F	854	$106.94	Disposed	106318	Direct
2018-11-09	ResMed Common Stock	F	1083	$106.94	Disposed	105235	Direct
2018-11-09	ResMed Common Stock	F	1199	$106.94	Disposed	104036	Direct
2018-11-12	ResMed Common Stock	M	1717	$58.24	Acquired	105753	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-12	ResMed Common Stock Options	$58.24	M	1717	Disposed	2022-11-19	ResMed Common Stock (1717)	Direct

Footnotes

F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.

F4: Represents date incentive stock options first became exercisable.